Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
Not applicable · Testing adapted physical activity · 2 sites · Raincy Montfermeil Hospital Group
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing adapted physical activity (a procedure) as supportive care (to help with symptoms or quality of life). Condition(s) listed: Inflammatory Bowel Disease (IBD) and Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Adults aged 18 years and older
- Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months
- Patient is motivated to participate in the Adapted Physical Activity (APA) program
Plus 4 more requirement(s). There are also 10 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 72 participants are expected to take part.
- Start date: 2025-09-15.
- Main results expected around 2025-10-30 (estimate from the record).
- 2 study sites listed (1 marked recruiting) in France.
Main thing being measured
- Impact of a Remote Adapted Physical Activity Program Delivered via the MOOV+ Application on Quality of Life in Patients With Inflammatory Bowel Disease: A Pilot Before-and-After Study (From baseline (Month 0) to Month 3)
In the researchers’ words
Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular physical activity.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (IBD); Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis) |
| Lead sponsor | Raincy Montfermeil Hospital Group |
| Collaborators | Janssen Cilag S.A.S. |
| Enrollment | 72 (estimated) |
| Start date | 2025-09-15 |
| Primary completion (est.) | 2025-10-30 |
| First posted | 2025-09-24 |
| Last updated | 2025-09-24 |
| Official title | Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD) |
| ClinicalTrials.gov ID | NCT07191106 |
Interventions
- adapted physical activity (Procedure)
Comparative before-and-after study over a 3-month period of remote Adapted Physical Activity (APA) delivered through the MOOV+ application
Full eligibility criteria (from the record)
Inclusion Criteria: * Adults aged 18 years and older * Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months * Patient is motivated to participate in the Adapted Physical Activity (APA) program * Medical certificate confirming fitness to engage in remote physical activity * Access to a digital device with internet connectivity enabling use of the MOOV+ application at home * Written informed consent freely given after appropriate information * Affiliation with, or beneficiary of, a national health insurance system Exclusion Criteria: * Patients under 18 years of age * Medical contraindication to physical activity * High levels of physical activity as defined by the International Physical Activity Questionnaire (IPAQ): * Total >1500 MET-min/week of vigorous activity on at least 3 days, OR * Total physical activity >3000 MET-min/week, regardless of distribution * Presence of psychological disorders that may interfere with study participation * Lack of access to a device or internet connection enabling remote participation * Pregnant or breastfeeding women * Patients under legal guardianship or curatorship * Patients under legal protection
Locations (2)
| Site | City | Country | Site status |
|---|---|---|---|
| GHI Le Raincy Montfermeil | Montfermeil | France | Recruiting |
| CHU Nantes | Nantes | France | Not yet recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.